Prognostic Value of Modified Coronary Flow Capacity Derived From [15O]H2O Positron Emission Tomography Perfusion Imaging

dc.contributor.authorde Winter Ruben W
dc.contributor.authorJukema Ruurt A
dc.contributor.authorvan Diemen Pepijn A
dc.contributor.authorSchumacher Stefan P
dc.contributor.authorSomsen Yvemarie BO
dc.contributor.authorvan de Hoef Tim P
dc.contributor.authorvan Rossum Albert C
dc.contributor.authorTwisk Jos WR
dc.contributor.authorMaaniitty Teemu
dc.contributor.authorKnuuti Juhani
dc.contributor.authorSaraste Antti
dc.contributor.authorNap Alexander
dc.contributor.authorRaijmakers Pieter G
dc.contributor.authorDanad Ibrahim
dc.contributor.authorKnaapen Paul
dc.contributor.organizationfi=InFLAMES Lippulaiva|en=InFLAMES Flagship|
dc.contributor.organizationfi=PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=kliininen fysiologia ja isotooppilääketiede|en=Clinical Physiology and Isotope Medicine|
dc.contributor.organizationfi=sisätautioppi|en=Internal Medicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.14646305228
dc.contributor.organization-code1.2.246.10.2458963.20.40502528769
dc.contributor.organization-code1.2.246.10.2458963.20.68445910604
dc.contributor.organization-code1.2.246.10.2458963.20.75985703497
dc.converis.publication-id181496015
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/181496015
dc.date.accessioned2025-08-27T23:45:27Z
dc.date.available2025-08-27T23:45:27Z
dc.description.abstract<p>BACKGROUND</p><p>Coronary flow capacity (CFC) is a measure that integrates hyperemic myocardial blood flow and coronary flow reserve to quantify the pathophysiological impact of coronary artery disease on vasodilator capacity. This study explores the prognostic value of modified CFC derived from [<sup>15</sup>O]H<sub>2</sub>O positron emission tomography perfusion imaging.<br></p><p>METHODS</p><p>Quantitative rest/stress perfusion measurements were obtained from 1300 patients with known or suspected coronary artery disease. Patients were classified as having myocardial steal (n=38), severely reduced CFC (n=141), moderately reduced CFC (n=394), minimally reduced CFC (n=245), or normal flow (n=482) using previously defined thresholds. The end point was a composite of death and nonfatal myocardial infarction.<br></p><p>RESULTS</p><p>During a median follow-up of 5.5 (interquartile range, 3.7-7.8) years, the end point occurred in 153 (12%) patients. Myocardial steal (hazard ratio [HR], 6.70 [95% CI, 3.21-13.99]; <em>P</em><0.001), severely reduced CFC (HR, 2.35 [95% CI, 1.16-4.78]; <em>P</em>=0.018), and moderately reduced CFC (HR, 1.95 [95% CI, 1.11-3.41]; <em>P</em>=0.020) were associated with worse prognosis compared with normal flow, after adjusting for clinical characteristics. Similarly, in the overall population, increased resting myocardial blood flow (HR, 3.05 [95% CI, 1.68-5.54]; <em>P</em><0.001), decreased hyperemic myocardial blood flow (HR, 0.68 [95% CI, 0.52-0.90]; <em>P</em>=0.007) and decreased coronary flow reserve (HR, 0.55 [95% CI, 0.42-0.71]; <em>P</em><0.001) were independently associated with adverse outcome. In a model adjusted for the combined use of perfusion metrics, modified CFC demonstrated independent prognostic value (overall <em>P</em>=0.017).<br></p><p>CONCLUSIONS</p><p>[<sup>15</sup>O]H<sub>2</sub>O positron emission tomography-derived resting myocardial blood flow, hyperemic myocardial blood flow, coronary flow reserve, and CFC are prognostic factors for death and nonfatal myocardial infarction in patients with known or suspected coronary artery disease. Importantly, after adjustment for clinical characteristics and the combined use of [<sup>15</sup>O]H<sub>2</sub>O positron emission tomography perfusion metrics, modified CFC remained independently associated with adverse outcome.</p>
dc.identifier.eissn1942-0080
dc.identifier.jour-issn1941-9651
dc.identifier.olddbid204556
dc.identifier.oldhandle10024/187583
dc.identifier.urihttps://www.utupub.fi/handle/11111/53113
dc.identifier.urlhttps://doi.org/10.1161/CIRCIMAGING.122.014845
dc.identifier.urnURN:NBN:fi-fe2025082790483
dc.language.isoen
dc.okm.affiliatedauthorMaaniitty, Teemu
dc.okm.affiliatedauthorKnuuti, Juhani
dc.okm.affiliatedauthorSaraste, Antti
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3126 Surgery, anesthesiology, intensive care, radiologyen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.discipline3126 Kirurgia, anestesiologia, tehohoito, radiologiafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherLippincott Williams & Wilkins
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.articlenumbere014845
dc.relation.doi10.1161/CIRCIMAGING.122.014845
dc.relation.ispartofjournalCirculation: Cardiovascular Imaging
dc.relation.issue9
dc.relation.volume16
dc.source.identifierhttps://www.utupub.fi/handle/10024/187583
dc.titlePrognostic Value of Modified Coronary Flow Capacity Derived From [15O]H2O Positron Emission Tomography Perfusion Imaging
dc.year.issued2023

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
de-winter-et-al-2023-prognostic-value-of-modified-coronary-flow-capacity-derived-from-15o-h2o-positron-emission.pdf
Size:
822.07 KB
Format:
Adobe Portable Document Format